US Stock MarketDetailed Quotes

Treace Medical Concepts (TMCI)

Watchlist
  • 2.650
  • -0.050-1.85%
Close Jan 15 15:59 ET
  • 2.650
  • 0.0000.00%
Post 16:10 ET
168.85MMarket Cap-3.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Treace Medical Concepts (TMCI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
11.37%50.21M
6.60%47.39M
2.86%52.57M
11.89%209.36M
10.44%68.71M
10.62%45.09M
5.96%44.46M
21.12%51.11M
31.92%187.12M
25.00%62.21M
Operating revenue
11.37%50.21M
6.60%47.39M
2.86%52.57M
11.89%209.36M
10.44%68.71M
10.62%45.09M
5.96%44.46M
21.12%51.11M
31.92%187.12M
25.00%62.21M
Cost of revenue
17.36%10.51M
9.73%9.64M
5.43%10.68M
16.80%41.09M
15.36%13.23M
11.95%8.95M
14.41%8.78M
25.97%10.13M
37.79%35.18M
27.14%11.47M
Gross profit
9.89%39.71M
5.82%37.75M
2.23%41.89M
10.75%168.26M
9.33%55.48M
10.29%36.13M
4.07%35.67M
19.98%40.98M
30.64%151.94M
24.53%50.74M
Operating expense
8.03%55.38M
-4.08%54.73M
-4.13%57.48M
10.12%223.95M
-3.21%55.68M
1.36%51.27M
20.55%57.06M
25.07%59.95M
34.55%203.37M
30.01%57.53M
Selling and administrative expenses
9.50%50.7M
-5.15%49.23M
-5.08%51.91M
8.21%203.36M
-5.44%50.47M
0.16%46.3M
18.48%51.9M
22.84%54.69M
36.61%187.93M
31.80%53.37M
-Selling and marketing expense
5.02%34.42M
-12.20%33.08M
-10.43%36.12M
4.79%147.64M
-7.68%36.86M
-2.29%32.78M
11.57%37.68M
19.83%40.33M
34.74%140.89M
32.68%39.92M
-General and administrative expense
20.35%16.28M
13.55%16.14M
9.95%15.79M
18.48%55.72M
1.21%13.61M
6.64%13.53M
41.74%14.22M
32.19%14.36M
42.52%47.03M
29.24%13.45M
Research and development costs
-5.70%4.68M
6.61%5.5M
5.76%5.56M
33.35%20.59M
25.48%5.21M
14.09%4.96M
46.26%5.16M
54.13%5.26M
13.66%15.44M
10.75%4.15M
Operating profit
-3.58%-15.68M
20.62%-16.97M
17.85%-15.58M
-8.28%-55.69M
96.99%-204K
15.06%-15.13M
-63.82%-21.38M
-37.69%-18.97M
-47.59%-51.43M
-93.94%-6.78M
Net non-operating interest income expense
-186.18%-704K
-953.13%-546K
-315.60%-470K
-124.31%-379K
-202.47%-415K
-189.78%-246K
-90.67%64K
12.37%218K
150.53%1.56M
172.58%405K
Non-operating interest income
-40.58%634K
-43.68%775K
-45.21%841K
-27.49%4.88M
-47.40%899K
-32.04%1.07M
-30.08%1.38M
3.79%1.54M
412.26%6.73M
126.96%1.71M
Non-operating interest expense
1.90%1.34M
0.69%1.32M
-0.46%1.31M
1.72%5.26M
0.77%1.31M
1.31%1.31M
2.34%1.31M
2.49%1.32M
17.49%5.17M
-0.53%1.3M
Other net income (expense)
360.00%92K
8.93%122K
75.68%130K
-5.26%324K
22.92%118K
-13.04%20K
17.89%112K
-42.19%74K
107.00%342K
126.89%96K
Special income (charges)
----
----
----
--0
----
----
----
----
--0
----
Other non- operating income (expenses)
360.00%92K
8.93%122K
75.68%130K
-5.26%324K
22.92%118K
-13.04%20K
17.89%112K
-42.19%74K
184.86%342K
126.89%96K
Income before tax
-6.04%-16.29M
17.96%-17.4M
14.75%-15.92M
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
Income tax
Net income
-6.04%-16.29M
17.96%-17.4M
14.75%-15.92M
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
Net income continuous Operations
-6.04%-16.29M
17.96%-17.4M
14.75%-15.92M
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
Minority interest income
Net income attributable to the parent company
-6.04%-16.29M
17.96%-17.4M
14.75%-15.92M
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.04%-16.29M
17.96%-17.4M
14.75%-15.92M
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
Basic earnings per share
-4.00%-0.26
17.65%-0.28
16.67%-0.25
-11.11%-0.9
90.00%-0.01
10.71%-0.25
-70.00%-0.34
-30.43%-0.3
-5.19%-0.81
-25.00%-0.1
Diluted earnings per share
-4.00%-0.26
17.65%-0.28
16.67%-0.25
-11.11%-0.9
90.00%-0.01
10.71%-0.25
-70.00%-0.34
-30.43%-0.3
-5.19%-0.81
-25.00%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 11.37%50.21M6.60%47.39M2.86%52.57M11.89%209.36M10.44%68.71M10.62%45.09M5.96%44.46M21.12%51.11M31.92%187.12M25.00%62.21M
Operating revenue 11.37%50.21M6.60%47.39M2.86%52.57M11.89%209.36M10.44%68.71M10.62%45.09M5.96%44.46M21.12%51.11M31.92%187.12M25.00%62.21M
Cost of revenue 17.36%10.51M9.73%9.64M5.43%10.68M16.80%41.09M15.36%13.23M11.95%8.95M14.41%8.78M25.97%10.13M37.79%35.18M27.14%11.47M
Gross profit 9.89%39.71M5.82%37.75M2.23%41.89M10.75%168.26M9.33%55.48M10.29%36.13M4.07%35.67M19.98%40.98M30.64%151.94M24.53%50.74M
Operating expense 8.03%55.38M-4.08%54.73M-4.13%57.48M10.12%223.95M-3.21%55.68M1.36%51.27M20.55%57.06M25.07%59.95M34.55%203.37M30.01%57.53M
Selling and administrative expenses 9.50%50.7M-5.15%49.23M-5.08%51.91M8.21%203.36M-5.44%50.47M0.16%46.3M18.48%51.9M22.84%54.69M36.61%187.93M31.80%53.37M
-Selling and marketing expense 5.02%34.42M-12.20%33.08M-10.43%36.12M4.79%147.64M-7.68%36.86M-2.29%32.78M11.57%37.68M19.83%40.33M34.74%140.89M32.68%39.92M
-General and administrative expense 20.35%16.28M13.55%16.14M9.95%15.79M18.48%55.72M1.21%13.61M6.64%13.53M41.74%14.22M32.19%14.36M42.52%47.03M29.24%13.45M
Research and development costs -5.70%4.68M6.61%5.5M5.76%5.56M33.35%20.59M25.48%5.21M14.09%4.96M46.26%5.16M54.13%5.26M13.66%15.44M10.75%4.15M
Operating profit -3.58%-15.68M20.62%-16.97M17.85%-15.58M-8.28%-55.69M96.99%-204K15.06%-15.13M-63.82%-21.38M-37.69%-18.97M-47.59%-51.43M-93.94%-6.78M
Net non-operating interest income expense -186.18%-704K-953.13%-546K-315.60%-470K-124.31%-379K-202.47%-415K-189.78%-246K-90.67%64K12.37%218K150.53%1.56M172.58%405K
Non-operating interest income -40.58%634K-43.68%775K-45.21%841K-27.49%4.88M-47.40%899K-32.04%1.07M-30.08%1.38M3.79%1.54M412.26%6.73M126.96%1.71M
Non-operating interest expense 1.90%1.34M0.69%1.32M-0.46%1.31M1.72%5.26M0.77%1.31M1.31%1.31M2.34%1.31M2.49%1.32M17.49%5.17M-0.53%1.3M
Other net income (expense) 360.00%92K8.93%122K75.68%130K-5.26%324K22.92%118K-13.04%20K17.89%112K-42.19%74K107.00%342K126.89%96K
Special income (charges) --------------0------------------0----
Other non- operating income (expenses) 360.00%92K8.93%122K75.68%130K-5.26%324K22.92%118K-13.04%20K17.89%112K-42.19%74K184.86%342K126.89%96K
Income before tax -6.04%-16.29M17.96%-17.4M14.75%-15.92M-12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M
Income tax
Net income -6.04%-16.29M17.96%-17.4M14.75%-15.92M-12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M
Net income continuous Operations -6.04%-16.29M17.96%-17.4M14.75%-15.92M-12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M
Minority interest income
Net income attributable to the parent company -6.04%-16.29M17.96%-17.4M14.75%-15.92M-12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.04%-16.29M17.96%-17.4M14.75%-15.92M-12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M
Basic earnings per share -4.00%-0.2617.65%-0.2816.67%-0.25-11.11%-0.990.00%-0.0110.71%-0.25-70.00%-0.34-30.43%-0.3-5.19%-0.81-25.00%-0.1
Diluted earnings per share -4.00%-0.2617.65%-0.2816.67%-0.25-11.11%-0.990.00%-0.0110.71%-0.25-70.00%-0.34-30.43%-0.3-5.19%-0.81-25.00%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -